AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($182.28 B vs $150.83 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GILD | AMGN |
|---|---|---|
| Market cap | $150.83 B | $182.28 B |
| US-listed rank | #99 | #80 |
| Revenue (latest FY) | $29.44B | $36.75B |
| Net income (latest FY) | $8.51B | $7.71B |
| Net margin | 28.9% | 21.0% |
| P/E (trailing FY) | 17.7 | 23.6 |
| SEC filings | 981 | 1,011 |
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($182.28 B vs $150.83 B).
In their latest fiscal years, GILEAD SCIENCES, INC. reported $29.44B in revenue while AMGEN INC reported $36.75B.
Full pages: GILEAD SCIENCES, INC. and AMGEN INC, or browse the full rankings.